# Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With COVID-19

> **NCT04252118** · PHASE1 · UNKNOWN · sponsor: **Beijing 302 Hospital** · enrollment: 20 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **BIOLOGICAL:** MSCs

## Key facts

- **NCT ID:** NCT04252118
- **Lead sponsor:** Beijing 302 Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-27
- **Primary completion:** 2020-12
- **Final completion:** 2021-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2020-04-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04252118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04252118, "Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With COVID-19". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04252118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*